Zdrowie i gospodarka · 28/07/2021

FDA Announces Fiscal Year 2022 Outsourcing Facility Fee Rates

The Food and Drug Administration (FDA) has set the fiscal year 2022 rates for establishment and reinspection fees for outsourcing facilities that manufacture human drugs, effective October 1, 2021, and will remain in effect through September 30, 2022.